menu
    • menu

    Company profile for Insulet Corporation

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, wit...
    Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Insulet CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Nagog Park Acton, MA 01720
    Telephone
    Telephone
    (+1) 978-600-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.insulet.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Insulet To Present At 44Th J.P. Morgan Healthcare Conference
    Insulet To Present At 44Th J.P. Morgan Healthcare Conference

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216562336/en/Insulet-to-Participate-in-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Insulet Unveils FDA Clearance For Omnipod® 5 Algorithm
    Insulet Unveils FDA Clearance For Omnipod® 5 Algorithm

    04 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251204178236/en/Insulet-Announces-FDA-510k-Clearance-of-Omnipod-5-Algorithm-Enhancements-that-Redefine-Insulin-Delivery-and-Simplify-the-Pod-Experience

    BUSINESSWIRE
    04 Dec 2025
    Share Share
    Insulet Reveals Growth Strategy At 2025 Investor Conference
    Insulet Reveals Growth Strategy At 2025 Investor Conference

    20 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251120914903/en/Insulet-Outlines-Long-Term-Strategy-to-Drive-Growth-and-Value-Creation-at-2025-Investor-Day

    BUSINESSWIRE
    20 Nov 2025
    Share Share
    Insulet Reports Third Quarter 2025 Results
    Insulet Reports Third Quarter 2025 Results

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106377212/en/Insulet-Reports-Third-Quarter-2025-Results

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Insulet Push Targets Office Challenges For People With Diabetes
    Insulet Push Targets Office Challenges For People With Diabetes

    04 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign

    FIERCE PHARMA
    04 Nov 2025
    Share Share
    Insulet Promotes Inclusion for People With Diabetes This Month
    Insulet Promotes Inclusion for People With Diabetes This Month

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030324919/en/Insulet-Champions-Workplace-Inclusion-for-People-with-Diabetes-with-New-Data-and-Tools-Released-for-Diabetes-Awareness-Month

    BUSINESSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search